These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 7582730)

  • 1. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
    Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
    Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
    Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
    Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
    Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
    Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF
    Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
    Romicka AM; Gazda A; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome.
    Bertolaccini ML; Roch B; Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Br J Rheumatol; 1998 Nov; 37(11):1229-32. PubMed ID: 9851275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of deep venous thrombosis in the lower limbs and the pelvis and pulmonary embolism in patients with positive antiphospholipid antibodies.
    Kinuya K; Kakuda K; Matano S; Sato S; Sugimoto T; Asakura H; Kinuya S; Michigishi T; Tonami N
    Ann Nucl Med; 2001 Dec; 15(6):495-7. PubMed ID: 11831396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant.
    Nojima J; Suehisa E; Akita N; Toku M; Fushimi R; Tada H; Kuratsune H; Machii T; Kitani T; Amino N
    Br J Haematol; 1997 Mar; 96(3):447-50. PubMed ID: 9054646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Toku M; Tada H; Yamaguti K; Koike T; Kanakura Y; Kitani T; Amino N
    Am J Hematol; 1998 May; 58(1):55-60. PubMed ID: 9590150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticardiolipin antibodies in childhood rheumatic disorders.
    Gedalia A; Molina JF; García CO; Doggett S; Espinoza LR; Gharavi AE
    Lupus; 1998; 7(8):551-3. PubMed ID: 9863898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE).
    Shobha V; Rajasekhar L; Manuel S; Nayana V; Kavadichanda C; Kounassegarane D; Mathew AJ; Gupta R; Rathi M; Ghosh P; Tripathy SR; Das B; Selvam S; Singh AK; Singh A; Jain A; Aggarwal A
    Rheumatol Int; 2024 May; 44(5):819-829. PubMed ID: 38082159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.